The BRCA2 DDCV carriers were also at a higher risk of having a first-degree family history of breast cancer or ovarian cancer compared with the normal/polymorphic BRCA2 carriers (odds ratio = 3.69) after adjusting for BRCA1 mutation status. This evidence concerns the gene BRCA1 and ovarian carcinoma.